Cargando…

Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders

Detalles Bibliográficos
Autores principales:	Terada, Kazuki, Migita, Keisuke, Matsushima, Yukari, Kamei, Chiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676876/ https://www.ncbi.nlm.nih.gov/pubmed/31290438 http://dx.doi.org/10.4103/1673-5374.259609

Ejemplares similares

Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors
por: Terada, Kazuki, et al.
Publicado: (2018)

Lin28 as a therapeutic target for central nervous system regeneration and repair
por: Wang, Shuo, et al.
Publicado: (2023)

Sigma-1 receptor and neuroprotection: current outlook and potential therapeutic effects
por: Li Volti, Giovanni, et al.
Publicado: (2016)

Sigma-1 receptor: a potential new target for Parkinson's disease?
por: Francardo, Veronica
Publicado: (2014)

Engineering mesenchymal stromal/stem cell-derived extracellular vesicles with improved targeting and therapeutic efficiency for the treatment of central nervous system disorders
por: Iavorovschi, Alexandra M., et al.
Publicado: (2020)

Sigma-1 receptor: culprit and rescuer in motor neuron diseases
por: Liévens, Jean-Charles, et al.
Publicado: (2020)

Vascular inflammation in the central nervous system
por: Guo, Xinying, et al.
Publicado: (2022)

Progesterone for the treatment of central nervous system disorders: the many signaling roads for a single molecule
por: González, Susana Laura
Publicado: (2020)

Central Nervous System Histoplasmosis: An Updated Insight
por: Ramírez, José Antonio, et al.
Publicado: (2023)

On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system
por: Meena, Megha, et al.
Publicado: (2019)

Metabolic reprogramming of glial cells as a new target for central nervous system axon regeneration
por: Walden, Erin L., et al.
Publicado: (2021)

Deoxyribozymes: New Therapeutics to Treat Central Nervous System Disorders
por: Grimpe, Barbara
Publicado: (2011)

Ghosts in the shell: identification of microglia in the human central nervous system by P2Y12 receptor
por: Mildner, Alexander
Publicado: (2017)

The role of interleukin-6 in central nervous system demyelination
por: Petković, Filip, et al.
Publicado: (2016)

Chronic oligodendrocyte injury in central nervous system pathologies
por: Molina-Gonzalez, Irene, et al.
Publicado: (2022)

A New Concept of Associations between Gut Microbiota, Immunity and Central Nervous System for the Innovative Treatment of Neurodegenerative Disorders
por: Yoshikawa, Sayuri, et al.
Publicado: (2022)

Self-healing hydrogel for tissue repair in the central nervous system
por: Hsieh, Fu-Yu, et al.
Publicado: (2015)

Neuroprotective role of galectin-1 in central nervous system pathophysiology
por: Aalinkeel, Ravikumar, et al.
Publicado: (2016)

Central CB(2) receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential
por: Concannon, Ruth M., et al.
Publicado: (2016)

How do corticosteroids influence myelin genesis in the central nervous system?
por: Chari, Divya M.
Publicado: (2014)

Collagen 1 signaling at the central nervous system injury site and astrogliosis
por: Neo, Sin Hui, et al.
Publicado: (2017)

CXCR4 signaling in central nervous system regeneration: friend or foe?
por: Terheyden-Keighley, Daniel, et al.
Publicado: (2021)

Neuroinflammation and glial activation in the central nervous system: a metabolic perspective
por: Virtuoso, Assunta, et al.
Publicado: (2022)

Renin-angiotensin system in the central nervous system: focus on Huntington’s disease
por: de Miranda, Aline Silva, et al.
Publicado: (2023)

Axon guidance in regeneration of the mature central nervous system: step by step
por: Schaeffer, Julia, et al.
Publicado: (2023)

Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
por: Sałaciak, Kinga, et al.
Publicado: (2022)

The lymphatic system: a therapeutic target for central nervous system disorders
por: Xu, Jia-Qi, et al.
Publicado: (2022)

The necessary role of mTORC1 in central nervous system axon regeneration
por: Hu, Yang
Publicado: (2015)

The choline pathway as a strategy to promote central nervous system (CNS) remyelination
por: Skripuletz, Thomas, et al.
Publicado: (2015)

Role of granulocyte macrophage colony stimulating factor in regeneration of the central nervous system
por: Shanmugalingam, Ushananthini, et al.
Publicado: (2016)

Sox9 in the developing central nervous system: a jack of all trades?
por: Vogel, Julia K., et al.
Publicado: (2020)

How can proton pump inhibitors damage central and peripheral nervous systems?
por: Makunts, Tigran, et al.
Publicado: (2020)

Putting PLX5622 into perspective: microglia in central nervous system viral infection
por: Spiteri, Alanna G., et al.
Publicado: (2022)

Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
por: Abarca-Merlin, D. M., et al.
Publicado: (2019)

Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
por: Malar, Dicson S., et al.
Publicado: (2023)

Nuclear peroxisome proliferator activated receptor-gamma (PPARγ) as a therapeutic target to treat neurodegeneration and dependence elicited by drugs of abuse
por: Ciccocioppo, Roberto, et al.
Publicado: (2020)

Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?
por: Dinh, Quynh N., et al.
Publicado: (2016)

Pathways for Small Molecule Delivery to the Central Nervous System Across the Blood-Brain Barrier
por: Mikitsh, John L, et al.
Publicado: (2014)

Extracellular matrix based biomaterials for central nervous system tissue repair: the benefits and drawbacks
por: Kubinova, Sarka
Publicado: (2017)

Reassembly of the axon initial segment and nodes of Ranvier in regenerated axons of the central nervous system
por: Marin, Miguel A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mtk87c76ievkjdnfj2pndscnmk